Work

Phase I Multicentre Tax-Torc Trial of the Dual Mtorc1/2 Inhibitor Azd2014 (A) Plus Weekly Paclitaxel (P) in Patients (Pts) with Solid Tumours (Crukd/12/013)

Year: 2014

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1093/annonc/mdu331.28

Authors: B. Basu, D. Roda-Perez, H.H. Wong, N. Sathiyayogan, M. Parmar, A. Turner, K. Swales, S. Stimpson, E. Hall, M. Hategan, J. Garcia-Corbacho, T.A. Yap, L.R. Molife, B. Jimenez, S. Banerjee, S.B. Kaye, J.S. De Bono, U. Banerji

Institutions: Cambridge University Hospitals NHS Foundation Trust, Royal Marsden NHS Foundation Trust, Institute of Cancer Research, Royal Marsden Hospital

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W1909876617

FWCI: 0.137

Cites:

Cited by: 1

Related to: 10